Related Experiment Videos
Efficacy of zonisamide: our experience
Toshio Yamauchi1, Hiroshi Aikawa
1Department of Neuropsychiatry, Saitama Medical School, Morohonngo 38, Moroyama-machi Iruma-gun, Saitama 350 0495, Japan. XLF05564@niftyserve.or.jp
Seizure
|October 30, 2004
Summary
Zonisamide effectively treats partial and generalized seizures in epilepsy patients, showing sustained efficacy over time. Monotherapy with zonisamide may offer greater benefits than combination treatments.
Area of Science:
- Neurology
- Clinical Pharmacology
Background:
- Zonisamide is an antiepileptic drug used for various seizure types.
- Understanding its long-term effectiveness and optimal use is crucial for patient management.
Purpose of the Study:
- To evaluate the effectiveness of zonisamide in a large patient cohort across Japan.
- To assess zonisamide's efficacy in different epilepsy syndromes and seizure types.
- To compare outcomes between zonisamide monotherapy and polytherapy.
Main Methods:
- A prospective, long-term postmarketing survey of 1631 patients across Japan.
- Analysis of zonisamide use in 60 outpatients at Saitama Medical College.
- Data collected from individual physicians and 23 survey groups.
Main Results:
- Zonisamide demonstrated high effectiveness in partial seizures (70% improvement).
- Significant improvement was observed in generalized seizures (58%), myoclonic, and atypical absence seizures.
- Highly effective for generalized idiopathic epilepsy (>78%) and partial epilepsy (>58%).
- Lower efficacy noted in West syndrome and Lennox-Gastaut syndrome (28% improvement).
- Monotherapy patients showed greater improvement than polytherapy patients.
Conclusions:
- Zonisamide is highly effective for partial and generalized seizures.
- Long-term use of zonisamide does not appear to diminish its efficacy.
- Monotherapy may be more beneficial than polytherapy for certain epilepsy types.